# Medmain

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medmain

- Industry: Healthcare IT
- Headquarters: Fukuoka-shi, Japan
- Website: www.medmain.com/
- Total disclosed funding: $0.9M
- Latest round: Seed (Aug 17, 2018)
- Investors on record: 2

## About

Founded in 2018 and based in Fukuoka, Japan, Medmain Inc., operates as a provider of pathology diagnostic software that helps patients diagnose diseases and cancers. In May 2025, Medmain Inc. raised JPY 470 million in venture funding led by new investor One Capital, with participation from other new investors NIREMIA Collective and Plug and Play Ventures. The company offers comprehensive solutions for pathological diagnosis, ranging from digitizing pathological specimens to supporting pathological diagnosis using their proprietary software. This service supports pathological diagnosis sites with technology for storing, managing, viewing, and utilizing digitized pathological image data. The company will use the May 2025 funding to develop its AI and cloud platforms, strengthen its sales system, and hire employees.

## Funding rounds

- Seed, Aug 17, 2018, $0.9M — Deepcore, Beta Venture Capital

## Investors

- Deepcore (https://capitalatlas.ai/funds/deepcore) — Seed
- Beta Venture Capital (https://capitalatlas.ai/funds/beta-venture-capital) — Seed